Focusing on “Neurohealth Across the Entire Lifespan,” Jointly Exploring a New Paradigm for Medical-Engineering Convergence—The N7 Session of the 2nd Brain Science and Photonics Conference Comes to a Successful Close.

On April 26, 2026, the N7 session of the 2nd Brain Science and Photonics Conference—titled “Neurohealth Across the Lifespan: Molecular Nutritional Protection and Improvement of Developmental Disorders”—organized by the International Federation for Life Sciences and Translational Medicine, came to a successful close at the Wyndham Hotel in Hangzhou.

As one of the core sub-forums of the 2nd Brain Science and Photonics Conference, this session brought together experts and scholars from top global universities and clinical institutions—including the University of Wollongong in Australia, Fudan University, Peking University First Hospital, Peking Union Medical College Hospital, and Zhejiang University—as well as numerous representatives from industry, academia, and research. The event was co-chaired by Professor Huang Xufeng (University of Wollongong, Australia; President of the International Federation for Life Sciences and Translational Medicine) and Ms. Zhao Haiyan (Chairwoman of Renmiao Life; Founder of iReal). Through nine high-level academic presentations and a roundtable discussion focused on the industrial chain, the conference delved deeply into cross-age collaborative prevention and treatment strategies—from autism to Alzheimer’s disease. The entire conference featured a rich academic atmosphere and highly substantive content, laying a solid foundation for advancing this critical initiative aimed at safeguarding neurological health across all age groups! It received unanimous acclaim from participants across various sectors!

Academic Report: A Panoramic Analysis of the “Gut-Brain Axis” and “Precision Intervention” Across Nine Key Topics

The academic presentation session of this N7 sub-forum was chaired by Mr. Huang Fei, Secretary-General of the International Federation for Life Sciences and Translational Medicine. Nine presenters comprehensively showcased the latest breakthroughs in the field of neurological health, covering three major areas: basic mechanisms, clinical nutrition, and digital innovation!

Grand Scene of the 2nd Brain Science and Photonics Conference

Highlights from the Symposium on Lifelong Neurological Health: Molecular Nutrition Protection and Improvement of Developmental Disorders

Huang Fei  (International Life Sciences and Translational Medicine Alliance)

Session I: Fundamental Mechanisms and Immunomodulation—Unveiling the Mysteries of the "Gut-Brain Axis"

Professor Huang Xufeng (University of Wollongong, Australia) delivered the opening keynote, providing an in-depth analysis of the relationship between gut-brain axis immunity and major brain diseases. From an immunological perspective, he elucidated how modern dietary patterns influence brain health through the intestinal barrier, offering a novel theoretical foundation for dietary intervention in the prevention of major brain diseases.

Professors Yu Yinghua and Hu Minmin from Xuzhou Medical University subsequently revealed the tremendous potential of prebiotics, probiotics, and postbiotics in ameliorating cognitive impairment, as well as how obesity and high-fat diets exacerbate brain aging—one of the contributing factors to metabolic encephalopathy.

Top: Professor Huang Xufeng (University of Wollongong, Australia)

Bottom Left 1-2: Yu Yinghua (Xuzhou Medical University); Hu Minmin (Xuzhou Medical University)

Session II: Clinical Nutrition and Molecular Intervention—From "Dining Table" to "Brain"

In the field of clinical nutrition and molecular intervention, multiple experts explored the profound connection between "eating" and "the brain" from various dimensions. Professor Yang Yanling from Peking University First Hospital and Dr. Lu Shiyan from Peking Union Medical College Hospital shared, from clinical perspectives, the critical role of metabolic regulation and dietary strategies in autism prevention and treatment, emphasizing the possibility of achieving recovery through precise "metabolic addition and subtraction." Meanwhile, Professor Shen Lirong from Zhejiang University and Professor Dou Xiaobing from Zhejiang Chinese Medical University presented the latest discoveries in the anti-aging domain—the former confirming the significant efficacy of major royal jelly proteins in improving age-related memory decline, and the latter revealing the unique value of the traditional Chinese medicine monomer dehydrotrametenolic acid from Poria cocos in repairing the blood-brain barrier and delaying neurodegenerative pathologies. Furthermore, Dr. Xu Zhuo from the China Anti-Aging Promotion Association bridged the gap between clinical practice and industry, proposing an innovative "Symptom-Function-Food" integrated paradigm, offering new insights for advancing the functional development of food products.

Top Left 1-3: Professor Yang Yanling (Peking University First Hospital); Professor Shen Lirong (Zhejiang University); Professor Dou Xiaobing (Zhejiang Chinese Medical University)

Bottom Left 1-2: Dr. Lu Shiyan (Peking Union Medical College Hospital); Dr. Xu Zhuo (China Anti-Aging Promotion Association)

Session III: Digital Innovation and Big Data—AI-Empowered Precision Diagnosis and Treatment

Professor Cheng Wei (Fudan University) concluded the academic presentations by sharing how multi-omics big data and AI technologies can be leveraged to achieve early identification and risk prediction of Alzheimer's disease, proposing a "data-intelligence-driven" new pathway for precision diagnosis and treatment, and pointing the way forward for future brain science research.

Professor Cheng Wei (Fudan University)

Panel Discussion: Cross-Disciplinary Integration, Jointly Building an Industrial Ecosystem

Following the academic presentations, in the session titled "Metabolic Remodeling · Digital Integration for New Life—Precision Diagnosis and Treatment of Autism and Collaborative Innovation in the Industrial Chain," Ms. Zhao Haiyan, together with representatives from traditional medicine, modern medicine, and relevant enterprises, engaged in in-depth dialogue on topics including gut-brain axis nutritional metabolism in autism, AI digital therapeutics, and traditional Chinese medicine intervention. They jointly explored the critical pathways from fundamental research to clinical translation and industrial implementation. Ms. Zhao Haiyan called for the integration of multi-stakeholder forces from government, industry, academia, research, and medicine, utilizing emerging technologies such as AI digital therapeutics and non-invasive brain-computer interfaces to promote the establishment of early screening and standardized rehabilitation systems for autism.

Top Left 1-3: Shen Yuqin (CEO, Renmiao Life Technology); Ms. Zhao Haiyan (Chairwoman, Renmiao Life); Yin Xiaodong (Founder, Zhuosheng Capital)

Middle Left 1-3: Zhan Yuanwen (Chairman, Shenzhen Tianxing Technology); Symposium in Full Swing; Professor Yi Xiaoyan (Institute of Semiconductors, Chinese Academy of Sciences)

Bottom Left 1-3: Wei Yanjun (Vice Chairperson, Haizhou District Disabled Persons' Federation, Lianyungang); Mi Lan (President, Australian Chinese Medicine Charity Foundation); Xu Hengyong (Founder, Jiyuan Health)

This Symposium on Lifelong Neurological Health: Molecular Nutrition Protection and Improvement of Developmental Disorders successfully established a high-level interdisciplinary and cross-age academic platform. By examining age-related cognitive decline and childhood neurodevelopmental disorders within a unified framework, the conference not only deepened the understanding of shared mechanisms underlying the "gut-brain axis," but also, through the convergence of medical-engineering disciplines and industry-academia-research integration, provided practical and viable "Chinese Solutions" for safeguarding neurological health in these two priority populations—the elderly and children.

About The International Life Science and Translational Medicine Alliance (ILSTMA)

The International Life Science and Translational Medicine Alliance (ILSTMA) was established in September 2025 in Sydney, Australia. The organization is dedicated to building an international cooperation platform through transnational collaboration and cross-disciplinary integration, promoting the translational application of international medical achievements, and enhancing the medical innovation value chain. Its core functions include facilitating academic exchanges, accelerating technology transfer, bridging market cooperation nodes, and advancing policy coordination. ILSTMA focuses on frontier domains such as anti-brain aging, modernization of traditional Chinese medicine, medical AI, and high-end instrumentation, and has established international cooperation funds, joint laboratories, and talent development programs. Currently, the Alliance has assembled a world-class expert team including Academician Cheng Heping of the Chinese Academy of Sciences, Distinguished Professor Huang Xufeng of the University of Wollongong, Australia, and Member of the National Academy of Sciences Miguel Nicolelis, and is committed to constructing a full-chain translational mechanism from fundamental research to industrialization.

For more information, please visit: www.ilstma.com

2nd Brain Science and Photonics Conference

Co-hosted by International Life Science and Translational Medicine Alliance, ILSTMA, Australia High-Tech Industrialization Association, and the Chinese Society for Optical Engineering (CSOE), the 2nd Brain Science and Photonics Conference was successfully held in Hangzhou from April 25 to 27, 2026. The conference gathered top global expertise in brain science and optics, established an in-depth exchange platform integrating industry, academia, research, and application, focused on frontier developments in the field, jointly explored new pathways for technological advancement, promoted breakthroughs in core technology innovation and efficient transformation of scientific research achievements, consolidated development consensus, and jointly charted a new blueprint for industrial synergy.

For more information, please visit: https://b2b.csoe.org.cn/meeting/BSPC2026.html